Sign In
Buy KMB
$102.29
+0.750 (+0.739%)
At Close: Jun 12, 2026
Tylenol Maker Eyes Best Day Ever on Kimberly-Clark Deal
11:17am, Monday, 03'rd Nov 2025
Tylenol maker and former Johnson & Johnson (JNJ) spinoff Kenvue Inc (NYSE:KVUE) is 16.7% higher to trade at $16.74, after Kimberly-Clark Corp (NASDAQ:KMB) agreed to purchase the pharma name for $48.
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
10:44am, Monday, 03'rd Nov 2025
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.
10:33am, Monday, 03'rd Nov 2025
D.E. Shaw, one of the Tylenol-maker's largest shareholders, stood to lose over $200 million but is now expected to break even on its bet.
Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant
09:57am, Monday, 03'rd Nov 2025
Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion. CNBC's David Faber breaks down the details.
Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger
09:16am, Monday, 03'rd Nov 2025
Kleenex maker's deal for troubled Johnson & Johnson spinoff comes amid lawsuits and regulatory scrutiny
Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal
09:15am, Monday, 03'rd Nov 2025
This is a developing story.
Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal
08:40am, Monday, 03'rd Nov 2025
CNBC's David Faber joins 'Squawk Box' with the latest news.
5 Things to Know Before the Stock Market Opens
08:40am, Monday, 03'rd Nov 2025
Stock futures are pointing higher to start the week as investors look ahead to another slew of earnings reports; OPEC+ agreed to pause output hikes; China said it would suspend additional rare earth c
Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion
08:27am, Monday, 03'rd Nov 2025
Kenvue's stock, which had hit a record low in recent weeks, was headed for its best day ever while Kimberly-Clark's stock tumbled.
Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal
08:24am, Monday, 03'rd Nov 2025
Kenvue missed Wall Street estimates for third-quarter sales on Monday, while it also announced its acquisition by Kimberly-Clark for about $48.7 billion.
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session
08:14am, Monday, 03'rd Nov 2025
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining more than 100 points on Monday.
KMB Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Kimberly-Clark Corporation is Fair to Shareholders
07:57am, Monday, 03'rd Nov 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Kimberly-Clark Corporation (NASDAQ: KMB) and Kenvue Inc. is fair to Kimberly-Clark shar
Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant
07:49am, Monday, 03'rd Nov 2025
Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion. The combined company would bring together brands like Huggies and Kleenex with the likes of Ba
3 Safe and Steady Stocks for Any Market
07:03am, Monday, 03'rd Nov 2025
Just when investors thought this time just might be different, volatility came back in the door. A few words from Federal Reserve Chair Jerome Powell and heavier-than-expected capital expenditure guid
Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion
06:50am, Monday, 03'rd Nov 2025
Kimberly-Clark will buy Kenvue for cash and stock.
